Mental Health Clinics in Milford, MI Accepting Medicare
26 Mental Health Clinics found. Showing 21 - 26
 Michigan Mental Health Services, Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 735 Union St, Milford, MI 48381 Phone: 248-802-6038 |
Craig A. Fuelling, M.d., Pllc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 3725 S Hill Rd, Milford, MI 48381 Phone: 734-455-3361 Fax: 734-975-1604 |
Darcey L. Maher, Ph.d., P.c. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 504 Union St, Milford, MI 48381 Phone: 248-345-5307 Fax: 248-684-6007 |
Higgs & Associates Inc. Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1800 N Milford Rd Ste 201, Milford, MI 48381 Phone: 248-684-5631 Fax: 248-684-9348 |
Beth M. Berman Psy.d. Pc Psychologist Medicare: Medicare Enrolled Practice Location: 425 W Huron St, Suite 210, Milford, MI 48381 Phone: 248-505-8324 Fax: 248-926-2012 |
Progressive Lifestyle Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 525 Mill St, Milford, MI 48381 Phone: 248-676-2650 |
News Archive
Omeros receives EMA CHMP positive opinion for Omidria for cataract, IOL replacement surgery
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for both large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the European Medicines Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Omidria® (phenylephrine and ketorolac injection) 1%/0.3%.
European mobile health market to reach €2.45 billion in 2016
The European mobile health market forecasts strikingly high growth rates in coming years, despite the global financial crisis. Frost & Sullivan expects the market to grow from €393 million in 2011 to €2.45 billion in 2016 therefore, creating vast opportunities for industry players.
Breast cancer risk for women with atypical hyperplasia greater than previously thought, study finds
Women with atypical hyperplasia of the breast have a higher risk of developing breast cancer than previously thought, a Mayo Clinic study has found. Results of the study appear in a special report on breast cancer in the New England Journal of Medicine.
Blocking dopamine reduces drug seeking and taking behavior
Blocking dopamine receptors in different regions of the amygdala reduces drug seeking and taking behavior with varying longevity, according to research in rats published in eNeuro.
Effectiveness of COVID-19 vaccination during Delta variant predominance
A new study investigated the continued effectiveness of COVID-19 vaccination during the delta variant predominance in a diverse and urban healthcare setting.
› Verified 1 days ago
- 1
- 2(current)